Pirjo Helena Mäkelä

Pirjo Helena Mäkelä's AcademicInfluence.com Rankings

Pirjo Helena Mäkelä

Philosophy

#5861

World Rank

#8783

Historical Rank

Logic

#3068

World Rank

#4174

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Pirjo Helena Mäkelä's Degrees

PhD Medical Sciences University of Helsinki
Doctorate Medicine University of Helsinki

Why Is Pirjo Helena Mäkelä Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pirjo Helena Mäkelä's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION (1988) (1697)
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. (2001) (1470)
ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis (1983) (800)
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. (1983) (548)
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. (1983) (494)
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. (1991) (378)
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis (1985) (365)
Etiology of childhood pneumonia: serologic results of a prospective, population-based study. (1998) (352)
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. (1996) (350)
Risk factors for pneumonia in the elderly. (1994) (344)
Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. (1980) (338)
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. (1984) (337)
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. (1990) (327)
P-fimbriated clones among uropathogenic Escherichia coli strains (1984) (275)
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. (2003) (240)
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. (1997) (236)
Lipopolysaccharide nomenclature--past, present, and future (1986) (232)
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. (1977) (218)
Lactobacilli and bacteremia in southern Finland, 1989-1992. (1996) (205)
Characterization of the lipopolysaccharide from the polymyxin‐resistant pmrA mutants of Salmonella typhimurium (1981) (191)
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. (2001) (181)
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. (1984) (172)
Invasiveness of Serotypes and Clones of Streptococcus pneumoniae among Children in Finland (2005) (170)
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. (1985) (163)
Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. (1999) (163)
Homing potentials of circulating lymphocytes in humans depend on the site of activation: oral, but not parenteral, typhoid vaccination induces circulating antibody-secreting cells that all bear homing receptors directing them to the gut. (1997) (162)
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. (1983) (161)
First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants (1986) (144)
Bacterial coinfection in children hospitalized with respiratory syncytial virus infections (1989) (144)
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. (1981) (144)
Immunization with major outer membrane proteins in experimental salmonellosis of mice (1979) (143)
Antibody response to 14‐valent pneumococcal capsular polysaccharide vaccine in pre‐school age children (1986) (143)
Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. (1999) (138)
PNEUMOCOCCAL VACCINE AND OTITIS MEDIA (1980) (137)
[The expression of genes]. (1968) (130)
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin (1993) (121)
Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. (1981) (120)
Association of clinical signs and symptoms with bacterial findings in acute otitis media. (2004) (119)
The role of IFN-γ in murine Salmonella typhimurium infection (1990) (116)
EFFECT OF GROUP-A MENINGOCOCCAL VACCINE IN ARMY RECRUITS IN FINLAND (1975) (115)
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. (1989) (113)
SHIFT IN THE AGE-DISTRIBUTION OF MENINGOCOCCAL DISEASE AS PREDICTOR OF AN EPIDEMIC? (1982) (112)
Finnish Approach to the Treatment of Acute Otitis Media Report of the Finnish Consensus Conference (1987) (111)
ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE (1985) (109)
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. (1982) (108)
Risk factors of invasive Haemophilus influenzae type b disease among children in Finland. (1989) (108)
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. (1972) (104)
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. (1980) (104)
Ability of Pneumococcal Serotypes and Clones To Cause Acute Otitis Media: Implications for the Prevention of Otitis Media by Conjugate Vaccines (2004) (102)
The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. (1987) (101)
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins (1976) (99)
SAFETY OF COMMERCIAL PRODUCTS WITH VIABLE LACTOBACILLUS STRAINS (1996) (98)
Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children (1993) (97)
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae (1983) (96)
Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media. (2004) (94)
P-fimbriae of Escherichia coli are subject to phase variation (1983) (93)
Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide (1981) (91)
Local Immune Responses to Chlamydia pneumoniae in the Lungs of BALB/c Mice during Primary Infection and Reinfection (1998) (86)
A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media. (1981) (85)
Pneumococcal Acute Otitis Media in Relation to Pneumococcal Nasopharyngeal Carriage (2005) (79)
New Salmonella typhimurium mutants with altered outer membrane permeability (1984) (76)
Epidemiology of invasive Haemophilus influenzae type b disease. (1992) (72)
Longitudinal Study on Pneumococcal Carriage During the First Year of Life in Bangladesh (2007) (70)
Enterobacterial surface antigens : methods for molecular characterisation (1985) (70)
GENETIC ASPECTS OF BIOSYNTHESIS AND STRUCTURE OF SALMONELLA SOMATIC POLYSACCHARIDE (1966) (70)
Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella (1976) (67)
Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). (2000) (62)
Role of gamma interferon in late stages of murine salmonellosis (1993) (61)
Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination. (2010) (61)
A novel virulence‐associated cell surface structure composed of 47‐kd protein subunits in Yersinia enterocolitica. (1985) (60)
Enterobacterial common antigen. (1976) (60)
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. (1992) (60)
Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. (2009) (60)
Triggering infections in reactive arthritis. (1985) (59)
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. (1995) (58)
The effect of polyvalent pneumococcal polysaccharide vaccine on nasopharyngeal and nasal carriage of Streptococcus pneumoniae. (1980) (58)
Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. (2003) (58)
Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. (1992) (57)
Alternative complement pathway activation by Salmonella O polysaccharide as a virulence determinant in the mouse. (1987) (56)
The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity (1992) (56)
An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. (1984) (56)
Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. (2009) (55)
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. (1995) (55)
Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis (1975) (55)
Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. (1991) (55)
Structural investigations on the core polysaccharide of Escherichia coli 0100. (1971) (54)
Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. (1973) (54)
Endotoxaemia and acute pancreatitis: correlation between the severity of the disease and the anti-enterobacterial common antigen antibody titre. (1984) (54)
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. (1986) (54)
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. (1970) (53)
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus (1984) (50)
Evolution of conjugate vaccines (2002) (49)
Vaccines for Haemophilus influenzae type b as models for an otitis vaccine (1989) (48)
Protein K: a new major outer membrane protein found in encapsulated Escherichia coli (1979) (48)
Genetic Determination of Enzymes Synthesizing O-Specific Sugars of Salmonella Lipopolysaccharides (1966) (48)
Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. (1991) (47)
Mutants defective in the 33K outer membrane protein of Salmonella typhimurium (1979) (47)
Active immunity is seen as a reduction in the cell response to oral live vaccine. (1991) (46)
Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation. (1993) (45)
Antigenic properties of Chlamydia trachomatis lipopolysaccharide (1985) (45)
Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy. (1994) (45)
Genetic determination of bacterial virulence, with special reference to Salmonella. (1986) (45)
Acquired Immunity to Chlamydia pneumoniae Is Dependent on Gamma Interferon in Two Mouse Strains That Initially Differ in This Respect after Primary Challenge (2000) (45)
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen (1976) (44)
Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media (2001) (44)
Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. (1999) (44)
CHAPTER 10 – Genetic Aspects of Biosynthesis and Structure of Salmonella Lipopolysaccharide (1971) (43)
Glucosylation of lipopolysaccharide in Salmonella: biosynthesis of O antigen factor 12 2 . I. Over-all reaction. (1971) (42)
Genetics of the (gram-negative) bacterial surface (1978) (42)
The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland. (1978) (42)
Chlamydial pneumonitis and its serodiagnosis in infants. (1984) (41)
The Value of Nasopharyngeal Culture in Predicting the Etiology of Acute Otitis Media in Children Less Than Two Years of Age (2006) (41)
Bacterial involvement in parainfluenza virus infection in children. (1990) (40)
The role of IFN-gamma in murine Salmonella typhimurium infection. (1990) (40)
Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. (1995) (40)
Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. (1995) (39)
Occurrence of Salmonella typhimurium virulence plasmid-specific sequences in different serovars of Salmonella. (1989) (39)
Virulence characteristics of Escherichia coli in nosocomial urinary tract infection. (1993) (39)
Antibody-secreting cells in acute urinary tract infection as indicators of local immune response. (1994) (37)
rfaP mutants of Salmonella typhimurium. (1989) (37)
Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines. (1989) (37)
Molecular Pathogenesis of Gastrointestinal Infections (1991) (36)
Vaccination against meningococcal group A disease in Finland 1974-75. (1976) (36)
Mixed Infection Is Common in Children with Respiratory Adenovirus Infection (1991) (36)
HAEMOPHILUS INFLUENZAE TYPE B STRAINS OF OUTER MEMBRANE SUBTYPES 1 AND 1c CAUSE DIFFERENT TYPES OF INVASIVE DISEASE (1987) (34)
Effect of enterobacterial common antigen on mouse virulence of Salmonella typhimurium (1976) (34)
Localization by insertion mutagenesis of a virulence-associated region on the Salmonella typhimurium 96 kilobase pair plasmid. (1989) (34)
Efficacy of Pneumococcal Vaccination against Recurrent Otitis Media (1980) (34)
Glucosylation of Lipopolysaccharide in Salmonella: Mutants Negative for O Antigen Factor 122 (1973) (34)
Vaccines against encapsulated bacteria: a global agenda. (1987) (34)
Association between cerebral infarction and increased serum bacterial antibody levels in young adults (1986) (34)
The virulence plasmid does not contribute to growth of Salmonella in cultured murine macrophages. (1992) (33)
Participation of Lipopolysaccharide Genes in the Determination of the Enterobacterial Common Antigen: Analysis in Salmonella Groups B and C1 (1974) (33)
Lipopolysaccharide-induced non-specific resistance to systemic Escherichia coli infection in mice. (1988) (33)
The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis. (1995) (33)
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide. (1978) (33)
Branhamella catarrhalis as a cause of bacteremic pneumonia. (1983) (32)
Properties of Escherichia coli isolates from urinary tract infections in boys. (1988) (32)
Participation of Lipopolysaccharide Genes in the Determination of the Enterobacterial Common Antigen: Analysis of R Mutants of Salmonella minnesota (1974) (31)
The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes. (1995) (31)
The smooth lipopolysaccharide character of 1,4,(5),12 and 1,9,12 transductants formed as hybrids between groups B and D of salmonella. (1971) (31)
Bacterial induction of human activated lymphocyte killing and its inhibition by lipopolysaccharide (LPS). (1986) (31)
DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. (2004) (31)
Experience in Finland with Haemophilus influenzae type b vaccines. (1991) (30)
Evidence for the importance of O antigen specific antibodies in mouse-protective Salmonella outer membrane protein (porin) antisera. (1986) (30)
Molecular Recognition in Host-Parasite Interactions (1992) (29)
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony (1972) (29)
Genetic Determination of the O Antigens of Salmonella Groups B (4,5,12) and C1 (6,7) (1966) (28)
The effect of long term tetracycline treatment for acne vulgaris on the occurrence of R factors in the intestinal flora of man (1976) (28)
Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age. (1989) (28)
Monoclonal antibodies specific to porin of Haemophilus influenzae type b: localization of their cognate epitopes and tests of their biological activities (1992) (28)
The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci. (1999) (28)
Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. (1993) (28)
Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib) (2000) (27)
BIOSYNTHESIS OF O‐ANTIGENIC POLYSACCHARIDES IN SALMONELLA (1966) (27)
Glucosylation of lipopolysaccharide in Salmonella: biosynthesis of O antigen factor 12 2 . 3. The presence of 12 2 determinants in haptenic polysaccharides. (1971) (27)
Inheritance of the O antigens of Salmonella groups B and D. (1965) (26)
Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. (1996) (26)
Vaccines, coming of age after 200 years. (2000) (26)
Anti-PsaA and the risk of pneumococcal AOM and carriage. (2003) (26)
Biosynthesis of uridine diphosphate N-acetylmannosaminuronic acid in rff mutants of Salmonella tryphimurium (1978) (26)
Salmonella, complement and mouse macrophages. (1988) (26)
Association of P and other fimbriae with clinical pyelonephritis in children. (1985) (26)
Community-acquired pyelonephritis in adults: characteristics of E. coli isolates in bacteremic and non-bacteremic patients. (1994) (26)
Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. (1993) (25)
Adverse reactions and endotoxin content of polysaccharide vaccines. (1977) (25)
Isolation and genetic characterization of polymyxin-resistant mutants of Salmonella (1978) (25)
Evolution of the capsular regulatory genes in Streptococcus pneumoniae. (2009) (24)
Radioimmunoassay of capsular polysaccharide antigens of groups A and C meningococci and Haemophilus influenzae type b in cerebrospinal fluid. (1977) (24)
SEROLOGICAL EVIDENCE FOR THE ROLE OF BACTEROIDES FRAGILIS AND ENTEROBACTERIACEAE IN THE PATHOGENESIS OF ACUTE PELVIC INFLAMMATORY DISEASE (1981) (23)
Endotoxin and liver diseases. High titres of enterobacterial common antigen antibodies in patients with alcoholic cirrhosis. (1981) (23)
Modelling transmission, immunity and disease of Haemophilus influenzae type b in a structured population (2004) (23)
Finnish efficacy trials with Haemophilus influenzae type b vaccines. (1992) (22)
Clinical experience with Haemophilus influenzae type b conjugate vaccines. (1990) (22)
Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100. (1996) (21)
Bacterial infection in under school age children with expiratory difficulty (1991) (21)
Lipopolysaccharide Modification Accompanying Antigenic Conversion by Phage P27 (1978) (21)
Invasive Escherichia coli infections in children: bacterial characteristics in different age groups and clinical entities (1993) (21)
Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues. (1998) (20)
Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model (2004) (20)
Possibilities of preventing otitis media by vaccination. (1983) (20)
Bacteriophage Attachment to the Somatic Antigen of Salmonella: Effect of O-Specific Structures in Leaky R Mutants and S, T1 Hybrids (1970) (20)
Haemophilus influenzae type b and cross-reactive antigens in natural Hib infection dynamics; modelling in two populations (2002) (20)
Biosynthesis of enterobacterial common antigen requires dTDPglucose pyrophosphorylase determined by a Salmonella typhimurium rfb gene and a Salmonella montevideo rfe gene (1986) (19)
Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? (2001) (19)
Modelling multi-type transmission of pneumococcal carriage in Bangladeshi families (2009) (19)
Conjugate vaccines--a breakthrough in vaccine development. (2003) (19)
On the effect of rfe mutation on the biosynthesis of the 08 and 09 antigens of E. coli. (1979) (18)
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium (1976) (18)
Lipopolysaccharide and mouse virulence of Salmonella: O antigen is important after intraperitoneal but not intravenous challenge (1984) (18)
The Group C2‐Type Modification of the B‐Type Lipopolysaccharide in a Hybrid between Salmonella Groups B and C2 (1972) (17)
Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media (2002) (17)
HFR males in Salmonella abony. (1963) (16)
Salmonella antigen 12-2: genetics of form variation. (1966) (16)
Salmonella bacteriophages that use outer membrane protein receptors (1977) (15)
History of Pneumococcal Immunization (2008) (15)
Vaccination of Children during Treatment for Leukemia (1986) (15)
Genetic determination of lipopolysaccharide: locus of O-specific unit polymerase in group E of salmonella. (1979) (13)
Immunization of elderly people with polyvalent pneumococcal vaccine (1989) (13)
O-Acetylation and glucosylation of lipopolysaccaride in hydrids between Salmonella groups B and C2. (1974) (12)
Genetic Analysis of Salmonella minnesota R Mutants with Defects in the Biosynthesis of the Lipopolysaccharide Core (1974) (12)
Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines. (2005) (12)
Predicting the course of meningococcal disease outbreaks in closed subpopulations (1999) (12)
Bacterial Involvement in Laryngeal Infections in Children (1990) (11)
Antigenic conversion by phage P27. I. Mapping of the prophage attachment site on the Salmonella chromosome. (1971) (10)
An F' episome of Salmonella abony. (1966) (10)
[Nobel laureates of medicine and physiology]. (1969) (9)
Comparative sensitivity of different serological tests for detecting chlamydial antibodies in perihepatitis. (1985) (9)
Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b. (1987) (9)
Use of vaccines for respiratory infections. Strategies for influenza and pneumococcal vaccines. (1990) (8)
Lipopolysaccharides of three classes of supersensitive mutants of Salmonella typhimurium (1985) (8)
The effects of traT insertion mutations on detergent sensitivity and serum resistance of Escherichia coli and Salmonella typhimurium (1987) (8)
Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide (1987) (8)
Susceptibility to invasive Haemophilus influenzae type b disease and the immunoglobulin G2m(n) allotype. (1991) (7)
Mouse virulence of Salmonella. Antigen-dependent differences are demonstrable, also after immunosuppression. (1971) (7)
GROUP-SPECIFIC MENINGOCOCCAL VACCINATION AND EPIDEMICS CAUSED BY OTHER GROUPS OF MENINGOCOCCI (1978) (7)
Enterobacterial common antigen in mutant strains of Salmonella (1978) (7)
Bacteriologic epidemiology of Hemophilus influenzae type b strains causing invasive infections in Finland. (1989) (7)
Effect of low level immunity on response to live rubella virus vaccine. (1986) (7)
The effect of lipopolysaccharide modification--antigenic factors 1,5,12 2 and 27--on the virulence of salmonella strains for mice. (1971) (7)
Predicting meningococcal disease outbreaks in structured populations (2004) (7)
INDICATIONS FOR PNEUMOCOCCAL VACCINE (1981) (6)
Vaccine-Induced Immunity to Pneumococcal Infection (2004) (6)
Serum antibodies and bacterial meningitis. (1991) (6)
Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response. (1983) (6)
Outer membrane protein-specific bacteriophages of Salmonella typhimurium. (1978) (6)
Field evaluation of the chessboard modification for serotyping of Streptococcus pneumoniae in a small laboratory in Bangladesh. (2006) (6)
The effect of T1 antigen on the virulence of salmonella strains for mice. (1971) (6)
Killing of Escherichia coli in the peritoneal cavity of convalescent mice; role of specific and non-specific immune mechanisms. (1988) (6)
INCIDENCE OF INVASIVE HAEMOPHILUS INFLUENZAE TYPE b INFECTIONS IN FILIPINO CHILDREN (2000) (6)
In vitro transformation of the Lewis blood groups of erythrocytes. (1967) (5)
Vaccination against infections by Chlamydia pneumoniae. (1999) (5)
CHLAMYDIA TWAR AND ACUTE MYOCARDIAL INFARCTION (1989) (5)
Oral administration of a certain strain of liveEscherichia coli for intestinal disorders? (Infection 23 [1995] 51–54) (1995) (5)
BACTERIAL ADHERENCE AND URINARY TRACT INFECTION (1982) (5)
Use of vaccines for respiratory infections (1990) (5)
How genes determine the structure of the Salmonella lipopolysaccharide. (1969) (5)
New bacterial vaccines (1982) (4)
Should we plan a general childhood vaccination against bacterial meningitis? (1979) (4)
Ability to Activate the Alternative Complement Pathway as a Virulence Determinant in Salmonellae (1988) (4)
Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine on the incidence of epiglottitis and meningitis. (1983) (4)
Capsular polysaccharide vaccines today (2005) (3)
Pneumococcal Vaccination in the Elderly (1999) (3)
Pneumococcal vaccination in the elderly: an underused option? (1999) (3)
The molecular biologist against infectious disease (2003) (3)
Diagnosis of pneumococcal pneumonia. (2001) (3)
T2 lipopolysaccharide antigen of Salmonella: comparison of the properties of T2 and mucoid forms (1976) (3)
Is cardiovascular disease preventable by vaccination? (1999) (3)
Capsular polysaccharide and conjugate vaccines. (1994) (2)
Salmonella as an Invasive Enteric Pathogen (1991) (2)
[Haemophilus diseases nearly eradicated in Finland]. (1992) (2)
The Virulence Plasmid of Salmonella Encodes a Protein Resembling Eukaryotic Tropomyosins (1993) (2)
Enterobacterial common antigen (1976) (2)
Pneumococcal vaccine and otitis media in infancy. (1983) (2)
Types and subtypes of group B meningococci isolated in Finland from 1976 through April 1986 (1988) (2)
Functional epidemiology of bacterial meningitis (2005) (2)
The Salmonella Typhimurium Virulence Plasmid (1991) (2)
New diagnostic methods in bacterial meningitis and pneumonia. (1982) (2)
[Haemophilus influenzae type B causing acute epiglottitis and meningitis]. (1968) (1)
Expression of the virulence plasmid-determined protein YOP1 and HeLa cell invasiveness of Yersinia enterocolitica O:3. (1991) (1)
Group A meningococcal polysaccharide vaccine (1986) (1)
[Were the meningococcal vaccination campaigns in 1974-76 of benefit?]. (1983) (1)
T2 lipopolysaccharide antigen of Salmonella: genetic determination of T2 and properties of the T2, T2,S, and T2,SR Forms (1976) (1)
Can otitis media be prevented with pneumococcal vaccine? (1980) (1)
[Continuous electrocardiography during activity and rest. Holter technic and its indications]. (1965) (1)
UnencapsulatedHaemophilus influenzae — What kind of pathogen? (1988) (1)
[The detection of bacteriuria by the dip slide method in a population study]. (1969) (1)
[Gene warfare]. (1993) (1)
The group C 2 -type modification of the B-type lipopolysaccharide in a hybrid between salmonella groups B and C 2 . (1972) (1)
Antimicrobial resistance in Haemophilus influenzae isolated from blood, cerebrospinal fluid, middle ear fluid and throat samples in children (1995) (1)
A genetic analysis of the O-antigenic conversion by phage 27 in group B Salmonellas. (1969) (0)
[Severe Haemophilus influenzae infections in children are contagious]. (1986) (0)
[Severe Haemophilus influenzae diseases and the possibilities of their prevention in Finland]. (1985) (0)
[Regulation of foreign genes in the cell: bacterial plasmids and lysogeny]. (1978) (0)
Lipopolysaccharide, H8 antigen and peptidoglycan in Neisseriae (1998) (0)
[Recurrent urinary tract infections and their prevention in women]. (1995) (0)
Alimentary tract andpancreas Endotoxaemia andacute pancreatitis: correlation between theseverity ofthedisease andtheanti- enterobacterial commonantigen antibody titre (1984) (0)
DEVELOPING VACCINES FOR PREVENTION OF CHRONIC DISEASE (2004) (0)
[Fluid therapy in burns]. (1966) (0)
RESPONSE TO A BOOSTER DOSE OF H.influenzae TYPE B CAPSULAR POLYSACCHARIDE - DIPHTERIA TOXOID CONJUGATE VACCINE (PRP-D) IN CHILDREN INITIALLY IMMUNIZED AT 3- 5-7 OR ONLY 7 MONTHS (1985) (0)
Characterization of the cell envelope of Yersinia enterocolitica and the immune response to its components (1983) (0)
Possible bottlenecks in vaccine use (1995) (0)
[Vaccines against gram-negative bacilli]. (1979) (0)
[Has meninogococcal infection been eradicated?]. (1976) (0)
[The operon--a functional genetic unit]. (1965) (0)
[Current microbiological methods in the diagnosis of urinary tract infections]. (1985) (0)
[Health, well being, peace and safety are closely connected to each other]. (2006) (0)
[Nobel Prize winners in medicine and physiology 1968]. (1968) (0)
Antibody-secreting cell responses after vaccination with parenteral killed, oral killed or oral live vaccine (1990) (0)
[New specific bacterial vaccines]. (1976) (0)
The molecular biologist against infectious disease. Infectious diseases, in both the developing and the developed world, still pose considerable challenges to biomedical research. But science alone is clearly not sufficient to overcome the burden of disease in the world. (2003) (0)
Research letterLipopolysaccharides of three classes of supersensitive mutants of Salmonella typhimurium (1985) (0)
[Meningitis vaccinations]. (1978) (0)
Role of brain polysialic acid in neural adhesion and bacterial meningitis (1984) (0)
[Ethylene oxide and hemodialysis anaphylaxis]. (1987) (0)
[Xanthogranulomatous cholecystitis--an unusual cause of gallbladder rupture]. (1994) (0)
[Synthetic gene technology for new vaccines]. (1988) (0)
Vaccines Against Bacterial Infections of Children (1991) (0)
Antibodies to lipopolysaccharide in the acute-phase sera of patients with meningitis due to Haemophilus influenzae type b. (1982) (0)
[Scientific misconduct]. (1995) (0)
Complement Activation and Use of Complement Receptors for Cell Entry in Salmonellosis (1992) (0)
[Something else than Koch's postulates. Robert Koch 1843-1910]. (1993) (0)
[Is pneumonia immunization necessary in the elderly?]. (1992) (0)
[Mode of action of various antibiotics]. (1970) (0)
[Mechanisms of microbial adhesion]. (1981) (0)
[Vaccines of the future]. (2002) (0)
What is ahead, FEMS? (1992) (0)
VACCINES – A BREAKTHROUGH IN VACCINE DEVELOPMENT (2008) (0)
[Why is erythromycin ineffective against enteric bacteria and how does E. coli cause urosepsis?]. (1985) (0)
MOUSE VIRULENCE OF SALMONELLA (2009) (0)
[How genes determine the structure of polysaccharides]. (1970) (0)
[Education and women's position]. (1997) (0)
Influence of O- and T1 side-chains on the attachment of bacteriophages to the somatic antigen of Salmonella. (1969) (0)
[The changing diagnostics of urinary infections]. (1969) (0)
Hightitres ofenterobacterial common antigen antibodies inpatients withalcoholic cirrhosis (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pirjo Helena Mäkelä?

Pirjo Helena Mäkelä is affiliated with the following schools:

University of Helsinki